These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9063344)

  • 1. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.
    Brett KM; Madans JH
    Am J Epidemiol; 1997 Mar; 145(6):536-45. PubMed ID: 9063344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement and menopausal symptoms following hysterectomy.
    Langenberg P; Kjerulff KH; Stolley PD
    Am J Epidemiol; 1997 Nov; 146(10):870-80. PubMed ID: 9384207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
    Lucas R; Barros H
    Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and breast cancer risk in a nationally representative cohort.
    Lando JF; Heck KE; Brett KM
    Am J Prev Med; 1999 Oct; 17(3):176-80. PubMed ID: 10987632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of hormonal replacement therapy in recently postmenopausal women.
    Ringa V; Ledésert B; Gueguen R; Schiele F; Breart G
    Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(3):193-200. PubMed ID: 1511767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
    Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
    J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study.
    Jang JH; Arora N; Kwon JS; Hanley GE
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1511-1517. PubMed ID: 32723606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prescriptions associated to hormone replacement therapy in Midi-Pyrénées region].
    Gass-Jégu F; Damase-Michel C; Hurault-Delarue C; Bourrel R; Montastruc JL
    Therapie; 2012; 67(2):121-8. PubMed ID: 22850098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
    Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
    J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of menopausal stage and patterns of hormone replacement therapy use.
    Bastian LA; Couchman GM; Rimer BK; McBride CM; Feaganes JR; Siegler IC
    J Womens Health; 1997 Aug; 6(4):467-75. PubMed ID: 9279835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample.
    Brett KM; Marsh JV; Madans JH
    J Womens Health; 1997 Jun; 6(3):309-16. PubMed ID: 9201665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.